| Wendy Cole-dean, RN | |
|
256 Sunset Lake Rd, Liberty, NY 12754-2847 | |
| (845) 513-2012 | |
| (845) 513-2177 |
| Full Name | Wendy Cole-dean |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Long-term Care |
| Location | 256 Sunset Lake Rd, Liberty, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134630056 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SL0600X | Clinical Nurse Specialist - Long-term Care | 476681-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Wendy Cole-dean, RN 256 Sunset Lake Rd, Liberty, NY 12754-2847 Ph: (845) 513-2012 | Wendy Cole-dean, RN 256 Sunset Lake Rd, Liberty, NY 12754-2847 Ph: (845) 513-2012 |
News Archive
Celsion Corporation today announced that Dr. Ronnie T.P. Poon from the University of Hong Kong and lead principal investigator for the Asia Pacific region of the Phase I ThermoDox dose escalation trial will hold a press conference on Thursday, April 15, 2010 at 10:30 AM HKT (Wednesday, April 14, 2010 10:30 PM ET) to discuss the long-term follow-up of patients treated from April 2006 to December 2006.
Illumina, Inc., the global leader in sequencing and array-based technologies, today announced the newest addition to its industry-leading next-generation sequencing (NGS) portfolio with the launch of the MiniSeq Sequencing System.
By focusing on the identification of common genetic variants, researchers have identified 57 single nucleotide polymorphisms (SNPs) that predict-with a high degree of certainty-the risk that siblings of children with Autism Spectrum Disorder (ASD) will also develop the condition. The findings were presented at the International Meeting for Autism Research.
Shionogi & Co., Ltd. announced today that Mulpleta (lusutrombopag), a once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo a procedure, is now available throughout the United States.
A new study by Yale Cancer Center and Smilow Cancer Hospital researchers suggests that the drug venetoclax aids therapy for relapsed/refractory myelodysplastic syndromes, especially when paired with azacytidine.
› Verified 7 days ago
Jenifer H Laymon, RN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 256 Sunset Lake Rd, Liberty, NY 12754 Phone: 845-513-2012 Fax: 845-513-2177 | |
Mrs. Donna Marie Funcheon, RN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 256 Sunset Lake Rd, Liberty, NY 12754 Phone: 845-513-2012 Fax: 845-513-2177 | |
Kimberly T Neves, RN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 256 Sunset Lake Rd, Liberty, NY 12754 Phone: 845-513-2012 Fax: 845-513-2177 | |
Mrs. Melissa Ann Fanning, RN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 256 Sunset Lake Rd, Liberty, NY 12754 Phone: 845-513-2012 Fax: 845-513-2177 | |
Margaret Catherine Voliva, RN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 256 Sunset Lake Rd, Liberty, NY 12754 Phone: 845-513-2012 Fax: 845-513-2177 | |
Susan Lee Madnick, RN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 256 Sunset Lake Rd, Liberty, NY 12754 Phone: 845-513-2012 Fax: 845-513-2177 |